Dr. Asad S. Mehdi, MD

Dr. Mehdi practices at Northwest Community Hospital in Arlington Heights, Illinois, part of Endeavor Health.

Dr. Mehdi's NPI, 1003072547, was assigned on August 4, 2008. Dr. Mehdi holds Illinois license 036126916.

Dr. Mehdi's primary practice is Northwest Community Hospital, at 800 W Central Road, Arlington Heights, IL 60005 in Cook County. The practice phone is (847) 618-1000.

Dr. Mehdi's primary practice is Northwest Community Hospital in Arlington Heights, Illinois, part of Endeavor Health. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Mehdi to 1 more hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehdi practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Mehdi's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Mehdi is board certified in family medicine by the American Board of Family Medicine. Dmand AI has Dr. Mehdi's licenses on file in 2 states: Illinois and Michigan.

CMS data shows 1,245 Medicare services from Dr. Mehdi across 5 procedure codes in 2024, for 435 Medicare patients. Medicare paid $109,639 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 435 Medicare patients who saw Dr. Mehdi in 2024. The largest group is 75 to 84, with 175 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehdi's median patient age at 72, with 55% women.

In 2024, Dr. Mehdi wrote 260 Medicare Part D claims for 147 patients. 95% of them were for generic drugs. CMS names the drug for 71 of them, across 4 drugs with 11 or more claims each, at $463 in total drug cost. In 2023, CMS named 63 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Mehdi for performance year 2024, reported as part of a group. Dr. Mehdi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Mehdi to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 13 general payments to Dr. Mehdi from 7 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $98.